SE453725B - Sett att framstella heparinhaltiga vattenextrakt - Google Patents
Sett att framstella heparinhaltiga vattenextraktInfo
- Publication number
- SE453725B SE453725B SE8002126A SE8002126A SE453725B SE 453725 B SE453725 B SE 453725B SE 8002126 A SE8002126 A SE 8002126A SE 8002126 A SE8002126 A SE 8002126A SE 453725 B SE453725 B SE 453725B
- Authority
- SE
- Sweden
- Prior art keywords
- heparin
- extraction
- volume
- content
- liters
- Prior art date
Links
- 239000000284 extract Substances 0.000 title description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title description 7
- 238000000605 extraction Methods 0.000 claims description 70
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 66
- 229920000669 heparin Polymers 0.000 claims description 66
- 229960002897 heparin Drugs 0.000 claims description 66
- 238000000034 method Methods 0.000 claims description 36
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 14
- 239000011780 sodium chloride Substances 0.000 claims description 10
- 239000006286 aqueous extract Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 235000004213 low-fat Nutrition 0.000 claims description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 36
- 239000000243 solution Substances 0.000 description 20
- 210000000056 organ Anatomy 0.000 description 18
- 208000035404 Autolysis Diseases 0.000 description 15
- 206010057248 Cell death Diseases 0.000 description 15
- 239000000463 material Substances 0.000 description 15
- 230000028043 self proteolysis Effects 0.000 description 15
- 230000017854 proteolysis Effects 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 239000007788 liquid Substances 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 210000001557 animal structure Anatomy 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 239000011368 organic material Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000009751 slip forming Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 229940021013 electrolyte solution Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Extraction Or Liquid Replacement (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU79RI705A HU177887B (en) | 1979-03-21 | 1979-03-21 | Process for preparing a raw material containing heparin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8002126L SE8002126L (sv) | 1980-09-22 |
| SE453725B true SE453725B (sv) | 1988-02-29 |
Family
ID=11001090
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8002126A SE453725B (sv) | 1979-03-21 | 1980-03-18 | Sett att framstella heparinhaltiga vattenextrakt |
| SE8002125A SE451297B (sv) | 1979-03-21 | 1980-03-18 | Sett att framstella heparinhaltigt ramaterial |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8002125A SE451297B (sv) | 1979-03-21 | 1980-03-18 | Sett att framstella heparinhaltigt ramaterial |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4315923A (en, 2012) |
| JP (2) | JPS55164201A (en, 2012) |
| AR (2) | AR222215A1 (en, 2012) |
| AT (2) | AT368004B (en, 2012) |
| AU (2) | AU533021B2 (en, 2012) |
| BE (2) | BE882370A (en, 2012) |
| BR (2) | BR8001717A (en, 2012) |
| CA (2) | CA1152894A (en, 2012) |
| CS (2) | CS248012B2 (en, 2012) |
| DD (2) | DD149532A5 (en, 2012) |
| DE (2) | DE3011062A1 (en, 2012) |
| DK (2) | DK166393C (en, 2012) |
| ES (2) | ES8102580A1 (en, 2012) |
| FR (2) | FR2451743A1 (en, 2012) |
| GB (2) | GB2045272B (en, 2012) |
| GR (2) | GR67681B (en, 2012) |
| HU (1) | HU177887B (en, 2012) |
| IN (1) | IN153527B (en, 2012) |
| IT (2) | IT1133068B (en, 2012) |
| NL (2) | NL8001693A (en, 2012) |
| NZ (2) | NZ193188A (en, 2012) |
| PL (2) | PL134709B1 (en, 2012) |
| SE (2) | SE453725B (en, 2012) |
| SU (2) | SU1366042A3 (en, 2012) |
| YU (2) | YU76580A (en, 2012) |
| ZA (2) | ZA801480B (en, 2012) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE449753B (sv) * | 1978-11-06 | 1987-05-18 | Choay Sa | Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav |
| US4692435A (en) * | 1978-11-06 | 1987-09-08 | Choay, S.A. | Mucopolysaccharide composition having a regulatory action on coagulation, medicament containing same and process of preparation |
| US4826600A (en) * | 1987-06-24 | 1989-05-02 | Amoco Corporation | Process for treatment of wastewater |
| FR2704226B1 (fr) * | 1993-04-22 | 1995-07-21 | Sanofi Elf | 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| EP0996642B1 (en) * | 1997-07-16 | 2006-01-11 | Akzo Nobel N.V. | Process for the production of heparin |
| CN1662151A (zh) * | 2002-06-19 | 2005-08-31 | 肯技术股份有限公司 | 包含粘膜副产品的动物饲料组合物 |
| CN118829681A (zh) * | 2022-03-08 | 2024-10-22 | 霍里松Ip有限公司 | 来自被屠宰动物的废弃组织的肝素以及天然蛋白质和肽的混合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2410084A (en) * | 1943-12-09 | 1946-10-29 | Upjohn Co | Recovery of heparin |
| US2587924A (en) * | 1948-05-27 | 1952-03-04 | Univ Alberta | Methods of producing heparin |
| US2571679A (en) * | 1948-07-08 | 1951-10-16 | Carlo Erba S A | Process for preparing purified heparin |
| DE950594C (de) * | 1953-07-01 | 1956-10-11 | Upjohn Co | Verfahren zur Gewinnung von Heparin |
| GB872214A (en) * | 1957-09-23 | 1961-07-05 | Upjohn Co | Extraction process for the recovery of heparin |
| US2989438A (en) * | 1958-12-29 | 1961-06-20 | Roussel Uclaf | Process of purifying heparin, and product produced therefrom |
| GB1221784A (en) * | 1967-04-07 | 1971-02-10 | John Ernest Scott | Precipitation of heparin from aqueous solution |
| US3451996A (en) * | 1968-02-12 | 1969-06-24 | Thompson Farms Co | Method for the preparation of heparin |
| IT1019525B (it) * | 1972-03-21 | 1977-11-30 | Ferdinando D | Metodo apparecchio e prodotto per formare complessi stabili di polia nioni |
| DE2646678C2 (de) * | 1975-10-31 | 1985-11-28 | A. H. Robins Co. Inc., Richmond, Va. | Verfahren zur Herstellung eines entfetteten Heparin-Gewebes |
| DE2646677C2 (de) * | 1975-10-31 | 1985-11-07 | A. H. Robins Co. Inc., Richmond, Va. | Verfahren zum Tempern von gefrorenem, Heparin führendem tierischem Gewebe |
| US4188467A (en) * | 1975-10-31 | 1980-02-12 | A. H. Robins Company, Incorporated | Process for tempering tissue for heparin production |
| US4192916A (en) * | 1975-10-31 | 1980-03-11 | A. H. Robins Company, Incorporated | Process for producing defatted heparin tissue for heparin production |
| DE2652272C2 (de) * | 1976-11-12 | 1979-02-15 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von Heparin |
| DE2660052A1 (de) * | 1976-11-12 | 1979-01-25 | Schering Ag | Verfahren zur herstellung von heparin |
| US4175182A (en) * | 1978-07-03 | 1979-11-20 | Research Corporation | Separation of high-activity heparin by affinity chromatography on supported protamine |
-
1979
- 1979-03-21 HU HU79RI705A patent/HU177887B/hu unknown
-
1980
- 1980-03-11 AT AT0134880A patent/AT368004B/de not_active IP Right Cessation
- 1980-03-13 ZA ZA00801480A patent/ZA801480B/xx unknown
- 1980-03-17 AT AT0144280A patent/AT365927B/de not_active IP Right Cessation
- 1980-03-18 ZA ZA00801564A patent/ZA801564B/xx unknown
- 1980-03-18 PL PL1980222794A patent/PL134709B1/pl unknown
- 1980-03-18 SE SE8002126A patent/SE453725B/sv not_active IP Right Cessation
- 1980-03-18 SE SE8002125A patent/SE451297B/sv not_active IP Right Cessation
- 1980-03-19 YU YU00765/80A patent/YU76580A/xx unknown
- 1980-03-19 US US06/131,824 patent/US4315923A/en not_active Expired - Lifetime
- 1980-03-19 CS CS801898A patent/CS248012B2/cs unknown
- 1980-03-19 CS CS801897A patent/CS248011B2/cs unknown
- 1980-03-19 GR GR61492A patent/GR67681B/el unknown
- 1980-03-19 GR GR61493A patent/GR67682B/el unknown
- 1980-03-20 AU AU56636/80A patent/AU533021B2/en not_active Ceased
- 1980-03-20 DK DK119480A patent/DK166393C/da not_active IP Right Cessation
- 1980-03-20 DD DD80219786A patent/DD149532A5/de not_active IP Right Cessation
- 1980-03-20 DD DD80219787A patent/DD149467A5/de unknown
- 1980-03-20 DK DK119780A patent/DK166504C/da not_active IP Right Cessation
- 1980-03-20 AU AU56637/80A patent/AU529809B2/en not_active Ceased
- 1980-03-20 SU SU802897057A patent/SU1366042A3/ru active
- 1980-03-20 SU SU802897802A patent/SU1375115A3/ru active
- 1980-03-20 NZ NZ193188A patent/NZ193188A/en unknown
- 1980-03-20 CA CA000348222A patent/CA1152894A/en not_active Expired
- 1980-03-20 FR FR8006266A patent/FR2451743A1/fr active Granted
- 1980-03-20 CA CA000348224A patent/CA1137081A/en not_active Expired
- 1980-03-20 YU YU00769/80A patent/YU76980A/xx unknown
- 1980-03-20 FR FR8006267A patent/FR2451744A1/fr active Granted
- 1980-03-21 ES ES490537A patent/ES8102580A1/es not_active Expired
- 1980-03-21 IT IT67438/80A patent/IT1133068B/it active
- 1980-03-21 JP JP3600680A patent/JPS55164201A/ja active Granted
- 1980-03-21 GB GB8009611A patent/GB2045272B/en not_active Expired
- 1980-03-21 NL NL8001693A patent/NL8001693A/nl not_active Application Discontinuation
- 1980-03-21 DE DE19803011062 patent/DE3011062A1/de not_active Withdrawn
- 1980-03-21 DE DE19803010972 patent/DE3010972A1/de active Granted
- 1980-03-21 BR BR8001717A patent/BR8001717A/pt unknown
- 1980-03-21 AR AR280393A patent/AR222215A1/es active
- 1980-03-21 AR AR280392A patent/AR219226A1/es active
- 1980-03-21 BE BE0/199895A patent/BE882370A/fr not_active IP Right Cessation
- 1980-03-21 IT IT67444/80A patent/IT1133074B/it active
- 1980-03-21 NL NL8001695A patent/NL8001695A/nl not_active Application Discontinuation
- 1980-03-21 NZ NZ193215A patent/NZ193215A/en unknown
- 1980-03-21 GB GB8009608A patent/GB2045271B/en not_active Expired
- 1980-03-21 JP JP3601280A patent/JPS55164202A/ja active Granted
- 1980-03-21 PL PL1980222906A patent/PL128250B1/pl unknown
- 1980-03-21 BR BR8001711A patent/BR8001711A/pt unknown
- 1980-03-21 ES ES490538A patent/ES8102581A1/es not_active Expired
- 1980-03-21 BE BE0/199894A patent/BE882369A/fr not_active IP Right Cessation
- 1980-08-21 IN IN952/CAL/80A patent/IN153527B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3716526A (en) | Refining of hemicelluloses | |
| EP0115023A2 (de) | Verfahren zur Gewinnung von Pankreatin | |
| WO2006116126A2 (en) | Extracting biopolymers from a biomass using ionic liquids | |
| EP0036699A1 (en) | Extraction of poly-beta-hydroxybutyric acid | |
| US3451996A (en) | Method for the preparation of heparin | |
| US3389133A (en) | Process for isolating and purifying soluble ribonucleic acid | |
| JPH05184306A (ja) | ツェインを含有する素材の処理方法 | |
| SE453725B (sv) | Sett att framstella heparinhaltiga vattenextrakt | |
| US2884358A (en) | Process for preparing crude heparin | |
| CS195253B2 (en) | Method of preparing pure starch hydrolysate from starch containing cereals | |
| JPH02171185A (ja) | 生理活性物質の調製方法 | |
| CN1654670A (zh) | 一种硫酸软骨素的制备方法 | |
| US2479481A (en) | Process for isolating cndenatured | |
| CN104151422A (zh) | 一种重组人生长激素的制备方法 | |
| JPH0678362B2 (ja) | デンプン分離方法 | |
| US2362993A (en) | Process for the separation of the hormone and hormonelike components of the pituitary gland | |
| CN110577608B (zh) | 分离纯化透明质酸的方法 | |
| DE2757377A1 (de) | Verfahren zum stabilisieren, konzentrieren und reinigen von insulin | |
| JPS6157520A (ja) | フコイダン純度の高い溶液又は、フコイダンの製造方法 | |
| CN104814244A (zh) | 一种高纯度甘薯蛋白的提取方法 | |
| JP2758475B2 (ja) | キトサンオリゴマー及びその製造法 | |
| US2882265A (en) | Process for recovering whole zein | |
| JP6887480B1 (ja) | 高純度の未変性コラーゲン及びその製造方法 | |
| KR880001120B1 (ko) | 엘라스타제의 정제 방법(Elastase의 精製方法) | |
| DE2121517A1 (en) | Purificn of amfotericin b - in dmf soln by adding water acidifying filtering adding water,making alkaline and washing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8002126-4 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8002126-4 Format of ref document f/p: F |